Author: Armin Fiechter
Publisher: Springer
ISBN: 3540449655
Category : Science
Languages : en
Pages : 186
Book Description
History of Modern Biotechnology, devided into two volumes (69 and 70), is devoted to the developments in different countries. A.L. Demain, A. Fang: The Natural Functions of Secondary Metabolites.- T. Beppu: Development of Applied Microbiology to Modern Biotechnology in Japan.- H. Kumagai: Microbial Production of Amino Acids in Japan.- T.K. Ghose, V.S. Bisaria: Development of Biotechnology in India.- M. Roehr: History of Biotechnology in Austria.- J. Hollo, U.P. Kralovánszky: Biotechnology in Hungary.- A. Fiechter: Biotechnology in Switzerland and a Glance at Germany.
History of Modern Biotechnology II
Author: Armin Fiechter
Publisher: Springer
ISBN: 3540449655
Category : Science
Languages : en
Pages : 186
Book Description
History of Modern Biotechnology, devided into two volumes (69 and 70), is devoted to the developments in different countries. A.L. Demain, A. Fang: The Natural Functions of Secondary Metabolites.- T. Beppu: Development of Applied Microbiology to Modern Biotechnology in Japan.- H. Kumagai: Microbial Production of Amino Acids in Japan.- T.K. Ghose, V.S. Bisaria: Development of Biotechnology in India.- M. Roehr: History of Biotechnology in Austria.- J. Hollo, U.P. Kralovánszky: Biotechnology in Hungary.- A. Fiechter: Biotechnology in Switzerland and a Glance at Germany.
Publisher: Springer
ISBN: 3540449655
Category : Science
Languages : en
Pages : 186
Book Description
History of Modern Biotechnology, devided into two volumes (69 and 70), is devoted to the developments in different countries. A.L. Demain, A. Fang: The Natural Functions of Secondary Metabolites.- T. Beppu: Development of Applied Microbiology to Modern Biotechnology in Japan.- H. Kumagai: Microbial Production of Amino Acids in Japan.- T.K. Ghose, V.S. Bisaria: Development of Biotechnology in India.- M. Roehr: History of Biotechnology in Austria.- J. Hollo, U.P. Kralovánszky: Biotechnology in Hungary.- A. Fiechter: Biotechnology in Switzerland and a Glance at Germany.
History of Modern Biotechnology I
Author: A. Fiechter
Publisher: Springer Science & Business Media
ISBN: 3540677933
Category : Medical
Languages : en
Pages : 231
Book Description
History of Modern Biotechnology, divided into two volumes (69 & 70), is devoted to the developments in different countries. N.W.F. Kossen: The Morphology of Filamentous Fungi.- H. Bockeer, W.A. Knorre: Antibiotica Research in Jena from Penicillin & Nourseothricin to Interferon.- K. Schugerl: Development of Bioreaction Engineering.- R. Katzen, G.T. Tsao: A View of the History of Biochemical Engineering.- J. M. Woodley: Selected Advances in Enzyme Technology.- H.R. Bungay: Computer Applications in Bioprocessing.- W. Beyeler, E. DaPra, K. Schneider: Automation of Industrial Bioprocesses.
Publisher: Springer Science & Business Media
ISBN: 3540677933
Category : Medical
Languages : en
Pages : 231
Book Description
History of Modern Biotechnology, divided into two volumes (69 & 70), is devoted to the developments in different countries. N.W.F. Kossen: The Morphology of Filamentous Fungi.- H. Bockeer, W.A. Knorre: Antibiotica Research in Jena from Penicillin & Nourseothricin to Interferon.- K. Schugerl: Development of Bioreaction Engineering.- R. Katzen, G.T. Tsao: A View of the History of Biochemical Engineering.- J. M. Woodley: Selected Advances in Enzyme Technology.- H.R. Bungay: Computer Applications in Bioprocessing.- W. Beyeler, E. DaPra, K. Schneider: Automation of Industrial Bioprocesses.
Modern Biotechnology
Author: Nathan S. Mosier
Publisher: John Wiley & Sons
ISBN: 1118210204
Category : Science
Languages : en
Pages : 415
Book Description
A unique resource for the next generation of biotech innovators Enabling everything from the deciphering of the human genome to environmentally friendly biofuels to lifesaving new pharmaceuticals, biotechnology has blossomed as an area of discovery and opportunity. Modern Biotechnology provides a much-needed introduction connecting the latest innovations in this area to key engineering fundamentals. With an unmatched level of coverage, this unique resource prepares a wide range of readers for the practical application of biotechnology in biopharmaceuticals, biofuels, and other bioproducts. Organized into fourteen sections, reflecting a typical semester course, Modern Biotechnology covers such key topics as: Metabolic engineering Enzymes and enzyme kinetics Biocatalysts and other new bioproducts Cell fusion Genetic engineering, DNA, RNA, and genes Genomes and genomics Production of biopharmaceuticals Fermentation modeling and process analysis Taking a practical, applications-based approach, the text presents discussions of important fundamentals in biology, biochemistry, and engineering with relevant case studies showing technology applications and manufacturing scale-up. Written for today's wider, more interdisciplinary readership, Modern Biotechnology offers a solid intellectual foundation for students and professionals entering the modern biotechnology industry.
Publisher: John Wiley & Sons
ISBN: 1118210204
Category : Science
Languages : en
Pages : 415
Book Description
A unique resource for the next generation of biotech innovators Enabling everything from the deciphering of the human genome to environmentally friendly biofuels to lifesaving new pharmaceuticals, biotechnology has blossomed as an area of discovery and opportunity. Modern Biotechnology provides a much-needed introduction connecting the latest innovations in this area to key engineering fundamentals. With an unmatched level of coverage, this unique resource prepares a wide range of readers for the practical application of biotechnology in biopharmaceuticals, biofuels, and other bioproducts. Organized into fourteen sections, reflecting a typical semester course, Modern Biotechnology covers such key topics as: Metabolic engineering Enzymes and enzyme kinetics Biocatalysts and other new bioproducts Cell fusion Genetic engineering, DNA, RNA, and genes Genomes and genomics Production of biopharmaceuticals Fermentation modeling and process analysis Taking a practical, applications-based approach, the text presents discussions of important fundamentals in biology, biochemistry, and engineering with relevant case studies showing technology applications and manufacturing scale-up. Written for today's wider, more interdisciplinary readership, Modern Biotechnology offers a solid intellectual foundation for students and professionals entering the modern biotechnology industry.
Biotech
Author: Eric J. Vettel
Publisher: University of Pennsylvania Press
ISBN: 0812203623
Category : History
Languages : en
Pages : 291
Book Description
The seemingly unlimited reach of powerful biotechnologies and the attendant growth of the multibillion-dollar industry have raised difficult questions about the scientific discoveries, political assumptions, and cultural patterns that gave rise to for-profit biological research. Given such extraordinary stakes, a history of the commercial biotechnology industry must inquire far beyond the predictable attention to scientists, discovery, and corporate sales. It must pursue how something so complex as the biotechnology industry was born, poised to become both a vanguard for contemporary world capitalism and a focal point for polemic ethical debate. In Biotech, Eric J. Vettel chronicles the story behind genetic engineering, recombinant DNA, cloning, and stem-cell research. It is a story about the meteoric rise of government support for scientific research during the Cold War, about activists and student protesters in the Vietnam era pressing for a new purpose in science, about politicians creating policy that alters the course of science, and also about the release of powerful entrepreneurial energies in universities and in venture capital that few realized existed. Most of all, it is a story about people—not just biologists but also followers and opponents who knew nothing about the biological sciences yet cared deeply about how biological research was done and how the resulting knowledge was used. Vettel weaves together these stories to illustrate how the biotechnology industry was born in the San Francisco Bay area, examining the anomalies, ironies, and paradoxes that contributed to its rise. Culled from oral histories, university records, and private corporate archives, including Cetus, the world's first biotechnology company, this compelling history shows how a cultural and political revolution in the 1960s resulted in a new scientific order: the practical application of biological knowledge supported by private investors expecting profitable returns eclipsed basic research supported by government agencies.
Publisher: University of Pennsylvania Press
ISBN: 0812203623
Category : History
Languages : en
Pages : 291
Book Description
The seemingly unlimited reach of powerful biotechnologies and the attendant growth of the multibillion-dollar industry have raised difficult questions about the scientific discoveries, political assumptions, and cultural patterns that gave rise to for-profit biological research. Given such extraordinary stakes, a history of the commercial biotechnology industry must inquire far beyond the predictable attention to scientists, discovery, and corporate sales. It must pursue how something so complex as the biotechnology industry was born, poised to become both a vanguard for contemporary world capitalism and a focal point for polemic ethical debate. In Biotech, Eric J. Vettel chronicles the story behind genetic engineering, recombinant DNA, cloning, and stem-cell research. It is a story about the meteoric rise of government support for scientific research during the Cold War, about activists and student protesters in the Vietnam era pressing for a new purpose in science, about politicians creating policy that alters the course of science, and also about the release of powerful entrepreneurial energies in universities and in venture capital that few realized existed. Most of all, it is a story about people—not just biologists but also followers and opponents who knew nothing about the biological sciences yet cared deeply about how biological research was done and how the resulting knowledge was used. Vettel weaves together these stories to illustrate how the biotechnology industry was born in the San Francisco Bay area, examining the anomalies, ironies, and paradoxes that contributed to its rise. Culled from oral histories, university records, and private corporate archives, including Cetus, the world's first biotechnology company, this compelling history shows how a cultural and political revolution in the 1960s resulted in a new scientific order: the practical application of biological knowledge supported by private investors expecting profitable returns eclipsed basic research supported by government agencies.
History of Modern Biotechnology I
Author: A. Fiechter
Publisher: Springer
ISBN: 3540449647
Category : Technology & Engineering
Languages : en
Pages : 231
Book Description
History of Modern Biotechnology, devided into two volumes (69 and 70), is devoted to the developments in different countries. A.L. Demain, A. Fang: The Natural Functions of Secondary Metabolites.- T. Beppu: Development of Applied Microbiology to Modern Biotechnology in Japan.- H. Kumagai: Microbial Production of Amino Acids in Japan.- T.K. Ghose, V.S. Bisaria: Development of Biotechnology in India.- M. Roehr: History of Biotechnology in Austria.- J. Hollo, U.P. Kralovánszky: Biotechnology in Hungary.- A. Fiechter: Biotechnology in Switzerland and a Glance at Germany.
Publisher: Springer
ISBN: 3540449647
Category : Technology & Engineering
Languages : en
Pages : 231
Book Description
History of Modern Biotechnology, devided into two volumes (69 and 70), is devoted to the developments in different countries. A.L. Demain, A. Fang: The Natural Functions of Secondary Metabolites.- T. Beppu: Development of Applied Microbiology to Modern Biotechnology in Japan.- H. Kumagai: Microbial Production of Amino Acids in Japan.- T.K. Ghose, V.S. Bisaria: Development of Biotechnology in India.- M. Roehr: History of Biotechnology in Austria.- J. Hollo, U.P. Kralovánszky: Biotechnology in Hungary.- A. Fiechter: Biotechnology in Switzerland and a Glance at Germany.
Industrialization of Biology
Author: National Research Council
Publisher: National Academies Press
ISBN: 0309316553
Category : Science
Languages : en
Pages : 158
Book Description
The tremendous progress in biology over the last half century - from Watson and Crick's elucidation of the structure of DNA to today's astonishing, rapid progress in the field of synthetic biology - has positioned us for significant innovation in chemical production. New bio-based chemicals, improved public health through improved drugs and diagnostics, and biofuels that reduce our dependency on oil are all results of research and innovation in the biological sciences. In the past decade, we have witnessed major advances made possible by biotechnology in areas such as rapid, low-cost DNA sequencing, metabolic engineering, and high-throughput screening. The manufacturing of chemicals using biological synthesis and engineering could expand even faster. A proactive strategy - implemented through the development of a technical roadmap similar to those that enabled sustained growth in the semiconductor industry and our explorations of space - is needed if we are to realize the widespread benefits of accelerating the industrialization of biology. Industrialization of Biology presents such a roadmap to achieve key technical milestones for chemical manufacturing through biological routes. This report examines the technical, economic, and societal factors that limit the adoption of bioprocessing in the chemical industry today and which, if surmounted, would markedly accelerate the advanced manufacturing of chemicals via industrial biotechnology. Working at the interface of synthetic chemistry, metabolic engineering, molecular biology, and synthetic biology, Industrialization of Biology identifies key technical goals for next-generation chemical manufacturing, then identifies the gaps in knowledge, tools, techniques, and systems required to meet those goals, and targets and timelines for achieving them. This report also considers the skills necessary to accomplish the roadmap goals, and what training opportunities are required to produce the cadre of skilled scientists and engineers needed.
Publisher: National Academies Press
ISBN: 0309316553
Category : Science
Languages : en
Pages : 158
Book Description
The tremendous progress in biology over the last half century - from Watson and Crick's elucidation of the structure of DNA to today's astonishing, rapid progress in the field of synthetic biology - has positioned us for significant innovation in chemical production. New bio-based chemicals, improved public health through improved drugs and diagnostics, and biofuels that reduce our dependency on oil are all results of research and innovation in the biological sciences. In the past decade, we have witnessed major advances made possible by biotechnology in areas such as rapid, low-cost DNA sequencing, metabolic engineering, and high-throughput screening. The manufacturing of chemicals using biological synthesis and engineering could expand even faster. A proactive strategy - implemented through the development of a technical roadmap similar to those that enabled sustained growth in the semiconductor industry and our explorations of space - is needed if we are to realize the widespread benefits of accelerating the industrialization of biology. Industrialization of Biology presents such a roadmap to achieve key technical milestones for chemical manufacturing through biological routes. This report examines the technical, economic, and societal factors that limit the adoption of bioprocessing in the chemical industry today and which, if surmounted, would markedly accelerate the advanced manufacturing of chemicals via industrial biotechnology. Working at the interface of synthetic chemistry, metabolic engineering, molecular biology, and synthetic biology, Industrialization of Biology identifies key technical goals for next-generation chemical manufacturing, then identifies the gaps in knowledge, tools, techniques, and systems required to meet those goals, and targets and timelines for achieving them. This report also considers the skills necessary to accomplish the roadmap goals, and what training opportunities are required to produce the cadre of skilled scientists and engineers needed.
The Uses of Life
Author: Robert Bud
Publisher: Cambridge University Press
ISBN: 9780521476997
Category : Medical
Languages : en
Pages : 324
Book Description
This book shows, for the first time, how modern biotechnology grew out of this century's hopes for a new relationship between biology and engineering. Long before recombinant DNA, these promised a new kind of technology. By exploring the rich and surprisingly overlooked complex of prophesies, industrial and scientific development and government programs, the book sheds new light on the expectations now held for biotechnology. A world-wide view, covering developments, not just in America but also in Europe and Japan, uncovers surprising links. This makes possible a coherent story to supersede the historical notes which have been available until now. This first history of biotechnology provides a readable and challenging account that will appeal to anyone interested in the development of this key component of modern industry.
Publisher: Cambridge University Press
ISBN: 9780521476997
Category : Medical
Languages : en
Pages : 324
Book Description
This book shows, for the first time, how modern biotechnology grew out of this century's hopes for a new relationship between biology and engineering. Long before recombinant DNA, these promised a new kind of technology. By exploring the rich and surprisingly overlooked complex of prophesies, industrial and scientific development and government programs, the book sheds new light on the expectations now held for biotechnology. A world-wide view, covering developments, not just in America but also in Europe and Japan, uncovers surprising links. This makes possible a coherent story to supersede the historical notes which have been available until now. This first history of biotechnology provides a readable and challenging account that will appeal to anyone interested in the development of this key component of modern industry.
Introduction to Pharmaceutical Biotechnology, Volume 1 (Second Edition): Basic Techniques and Concepts
Author:
Publisher:
ISBN: 9780750353830
Category : Medical
Languages : en
Pages : 0
Book Description
Publisher:
ISBN: 9780750353830
Category : Medical
Languages : en
Pages : 0
Book Description
Gene Jockeys
Author: Nicolas Rasmussen
Publisher: JHU Press
ISBN: 1421413418
Category : Medical
Languages : en
Pages : 260
Book Description
The scientific scramble to discover the first generation of drugs created through genetic engineering. The biotech arena emerged in the 1970s and 1980s, when molecular biology, one of the fastest-moving areas of basic science in the twentieth century, met the business world. Gene Jockeys is a detailed study of the biotech projects that led to five of the first ten recombinant DNA drugs to be approved for medical use in the United States: human insulin, human growth hormone, alpha interferon, erythropoietin, and tissue plasminogen activator. Drawing on corporate documents obtained from patent litigation, as well as interviews with the ambitious biologists who called themselves gene jockeys, historian Nicolas Rasmussen chronicles the remarkable, and often secretive, work of the scientists who built a new domain between academia and the drug industry in the pursuit of intellectual rewards and big payouts. In contrast to some who critique the rise of biotechnology, Rasmussen contends that biotech was not a swindle, even if the public did pay a very high price for the development of what began as public scientific resources. Within the biotech enterprise, the work of corporate scientists went well beyond what biologists had already accomplished within universities, and it accelerated the medical use of the new drugs by several years. In his technically detailed and readable narrative, Rasmussen focuses on the visible and often heavy hands that construct and maintain the markets in public goods like science. He looks closely at how science follows money, and vice versa, as researchers respond to the pressures and potential rewards of commercially viable innovations. In biotechnology, many of those engaged in crafting markets for genetically engineered drugs were biologists themselves who were in fact trying to do science. This book captures that heady, fleeting moment when a biologist could expect to do great science through the private sector and be rewarded with both wealth and scientific acclaim.
Publisher: JHU Press
ISBN: 1421413418
Category : Medical
Languages : en
Pages : 260
Book Description
The scientific scramble to discover the first generation of drugs created through genetic engineering. The biotech arena emerged in the 1970s and 1980s, when molecular biology, one of the fastest-moving areas of basic science in the twentieth century, met the business world. Gene Jockeys is a detailed study of the biotech projects that led to five of the first ten recombinant DNA drugs to be approved for medical use in the United States: human insulin, human growth hormone, alpha interferon, erythropoietin, and tissue plasminogen activator. Drawing on corporate documents obtained from patent litigation, as well as interviews with the ambitious biologists who called themselves gene jockeys, historian Nicolas Rasmussen chronicles the remarkable, and often secretive, work of the scientists who built a new domain between academia and the drug industry in the pursuit of intellectual rewards and big payouts. In contrast to some who critique the rise of biotechnology, Rasmussen contends that biotech was not a swindle, even if the public did pay a very high price for the development of what began as public scientific resources. Within the biotech enterprise, the work of corporate scientists went well beyond what biologists had already accomplished within universities, and it accelerated the medical use of the new drugs by several years. In his technically detailed and readable narrative, Rasmussen focuses on the visible and often heavy hands that construct and maintain the markets in public goods like science. He looks closely at how science follows money, and vice versa, as researchers respond to the pressures and potential rewards of commercially viable innovations. In biotechnology, many of those engaged in crafting markets for genetically engineered drugs were biologists themselves who were in fact trying to do science. This book captures that heady, fleeting moment when a biologist could expect to do great science through the private sector and be rewarded with both wealth and scientific acclaim.
Opportunities in Biotechnology for Future Army Applications
Author: National Research Council
Publisher: National Academies Press
ISBN: 0309075556
Category : Science
Languages : en
Pages : 118
Book Description
This report surveys opportunities for future Army applications in biotechnology, including sensors, electronics and computers, materials, logistics, and medical therapeutics, by matching commercial trends and developments with enduring Army requirements. Several biotechnology areas are identified as important for the Army to exploit, either by direct funding of research or by indirect influence of commercial sources, to achieve significant gains in combat effectiveness before 2025.
Publisher: National Academies Press
ISBN: 0309075556
Category : Science
Languages : en
Pages : 118
Book Description
This report surveys opportunities for future Army applications in biotechnology, including sensors, electronics and computers, materials, logistics, and medical therapeutics, by matching commercial trends and developments with enduring Army requirements. Several biotechnology areas are identified as important for the Army to exploit, either by direct funding of research or by indirect influence of commercial sources, to achieve significant gains in combat effectiveness before 2025.